Drug Keytruda May Help Block Melanoma's Return

MONDAY, April 16, 2018 (HealthDay News) — Taking the drug Keytruda after surgery for advanced melanoma significantly reduced patients’ risk of their cancer returning, a new study found. Last May, Keytruda (pembrolizumab) became the first ever drug approved by the U.S. Food and Drug Administration to fight cancers based on specific tumor genetics, rather than…

Details

A College Student's Guide to Avoiding Burnout

SUNDAY, April 15, 2018 (HealthDay News) — Juggling classes, jobs and extracurricular activities can lead to big-time burnout in college, but knowing its signs can help savvy students avoid it, one psychologist says. “Burnout is described as feeling apathy and lack of interest toward activities that were previously enjoyable, some amount of work avoidance and…

Details